Hydreight Q2 Revenue Soars 421% to $28M, Reaffirms $150M FY Guidance
VSQTF sits 60% above its 52-week low of $0.3 on light trading volume (0.2× avg).
Summary
Hydreight delivered record Q2 2026 results with revenue of $28.0 million, up 421% year-over-year and 12.5% sequentially. Net income reached $2.5 million and adjusted EBITDA $3.2 million, both sharply higher than the prior-year period. The company reaffirmed its fiscal 2026 revenue guidance of approximately $150 million, implying significant acceleration in the second half. Gross margin declined due to a higher mix of pharmacy sales, but the company maintains $20 million in cash and $35 million in working capital. The virtual healthcare/direct-to-consumer segment generated $22.8 million in Q2 revenue, up from $0.7 million a year ago, driven by the VSDHOne platform. Management will host an investor webcast on September 1, 2026, with a live analyst Q&A.
At the time of this announcement, VSQTF was trading at $0.48 on OTC in the Life Sciences sector, with a market capitalization of approximately $50.1M. The 52-week trading range was $0.30 to $0.72. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.